Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Inactivation or attenuation; producing viral subunits
Reexamination Certificate
2006-03-07
2006-03-07
Scheiner, Laurie (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Inactivation or attenuation; producing viral subunits
C424S188100, C424S208100, C435S320100, C435S238000
Reexamination Certificate
active
07008784
ABSTRACT:
The present invention is directed toward methods for the production of non-infectious, replication-deficient, immunogenic human immunodeficiency virus (HIV)-like particles. These particles are prepared from a recombinant expression vector comprising a heterologous promoter operatively connected to a DNA molecule comprising a modified HIV genome devoid of the long terminal repeat (LTR) regulatory regions but containing at least the gag and pol genes in their natural genomic arrangement. This vector is introduced into mammalian cells to produce the particles of interest. These particles should prove useful in a number of diagnostic, virologic, and immunologic applications.
REFERENCES:
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 0 241 239 (1987-10-01), None
patent: 0 315 459 (1989-05-01), None
patent: 0 335 635 (1989-10-01), None
patent: 0 381 146 (1990-08-01), None
patent: 2 181 435 (1987-04-01), None
patent: WO 88/03562 (1988-05-01), None
patent: WO 89/12905 (1989-12-01), None
patent: WO 90/15141 (1990-12-01), None
D.D. Loeb et al—Complete Mutagenesis of the HIV-1 Protease, pp. 397-400, Nature, vol. 340, No. 6232, Aug. 3, 1989.
Rovinski et al—J. Virology, (1992) vol. 66, pp. 4003-4012.
Slade et al—AIDS Research and Human Retroviruses, vol. 8, No. 8, (1992) pp. 1329-1331.
Hu, S.L. et al, 1986—Nature 320: 537-540.
Gheysen, D. et al, 1989—Cell 59:103-112.
Varmus, H. 1988—Science 240-1427-1435.
Desrosiers, R.C. et al, 1989—Proc. Natl. Acad. Sci.—86:6353-6357.
Bowie, J.U. et al; 1990 Science 247:1306-1310.
Lu, Y. et al, J. of Virology 63(9):4115-4119.
Sambrook, J. et al—Molecular Cloning—Cold Spring Harbor Lab Press (1989) p. 16.1-16.32.
Hunter, E., 1994, “Macromolecular interactions in the assembly of HIV and other retroviruses”, Sem. Virol. 5: 71-83.
Coffin, J., 1990, “Retroviridae and their replication”, in Virology Second Edition, Fileds et al., eds., Raven Press, Ltd., New York, p. 1493.
Karacostas et al., 1993, “Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activationof HIV-1 protease and inhibition of assembly and budding of virus-like particles”, Virol. 1993:661-671.
Karacostas et al., 1989, “Human immunodeficiency virus-like particles produced by a caccinina cirus expression vector”, Pro. Natl. Acad. Scu. USA 86:8964-8967.
Korman et al., 1987, “Expression of human class II mahor histocompatibility complex antigens using retrovirus vectors”, Pro. Natl. Acad. Sci. USA 84:2150-2154.
Cao Shi Xian
Haynes Joel
Klein Michel Henri
Rovinski Benjamin
Aventis Pasteur Limited
Parkin Jeffrey S.
Scheiner Laurie
Sim & McBurney
LandOfFree
Non-infectious, non-replicating, immunogenic human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-infectious, non-replicating, immunogenic human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-infectious, non-replicating, immunogenic human... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3529106